Biotechnology News

February 14, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences Awarded 7th Patent, 1st in Europe.

February 14, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced that it has increased its revolving line of credit with Comerica Bank from $25 million to $35 million and extended the maturity from July 11, 2013 to February 13, 2015. In...

February 14, 2012

RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today the launch of AptivAdvantageTM – a unique...

February 14, 2012

LONDON--(BUSINESS WIRE)--IntertechPira and EuropaBio now invite papers to be submitted for EFIB 2012. This year’s European Forum for Industrial Biotechnology and the Biobased Economy is 16-18 October in Dusseldorf, Germany.

February 14, 2012

LAUSANNE, Switzerland--(BUSINESS WIRE)--Data published in the IOVS journal shows that Gene Signal's aganirsen demonstrates activity in models of eye diseases such as AMD

February 14, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Karo Bio AB (publ) has decided to discontinue the development program for eprotirome after an animal study has demonstrated unwanted effects following long-term exposure. The planned spin-off of...

February 14, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: First mover in blood based CNS biomarkers The interim report for the fourth quarter 2011 was approved by the Board of Directors on 13 February 2011. Please find the interim report and presentation...

February 14, 2012

SOUTH SAN FRANCISO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) today announced the availability of the Access Array™ Barcode Library for the Ion Torrent Personal Genome Machine (PGM) sequencer.

February 14, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-...

February 14, 2012

SOUTH SAN FRANCISO, Calif.--(BUSINESS WIRE)--Fluidigm introduces Access Array™ Target-Specific Primers that allow for fast, simple, and inexpensive preparation of up to 480 amplicons per sample at a time for Illumina NGS Systems.

February 13, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL. Please visit the investor section of...

February 13, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc.

February 13, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River reports fourth-quarter and full-year 2011 results

February 13, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will provide a brief overview of the company followed by a question and answer period with investors at the following investor...

February 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex (Nasdaq: VRTX) today announced that Vertex will webcast its presentation from three upcoming investor conferences.

February 13, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today reported financial results for the fourth quarter and year ended December 31, 2011. The company also highlighted the ADCETRIS (brentuximab vedotin) product launch, recent...

February 13, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) announced today that it will report financial results for the fourth quarter and year ended December 31, 2011 on Tuesday, February 28, 2012. Company management will host a...

February 13, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaecuticals (NYSE AMEX: NAVB) President, Dr. Mark Pykett, to Participate in Panel Discussion on Companion Diagnostics at BIO CEO on February 14, 2012 at 10:30 am ET.

February 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All of these...

February 13, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the Leerink Swann 2012 Global Healthcare Conference will be webcast and may be accessed at...

February 13, 2012

HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials. The article, entitled Carbon...

February 13, 2012

DUBLIN, Ireland--(BUSINESS WIRE)--Venn Life Sciences (“Venn”), a leading provider of development consulting and resourcing services to the pharmaceutical, biotechnology and medical devices industries today announced a number of management changes...

February 13, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today released its second annual industry survey report of Europe’s key decision makers, 2011 European Trends in Aggregate Spend, Transparency and Disclosure, which provides a comparative...

February 13, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The disclosure notice published earlier today (February 13, 2012 01:15 PM UK time) contained a calculation error. The correct number of repurchased shares and percentages held appears below. The...

February 13, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, is hosting a series of events at Informa’s Cell Line Development and Engineering Meeting 2012 being held February 13-17 at the...

February 13, 2012

OXFORD, England & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Oxford Immunotec Ltd. an immunology focused diagnostic company, announces the appointment of Richard (Rick) Alteri as Chief Financial Officer (CFO). Prior to joining Oxford Immunotec, Mr...

February 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals today announced that the underwriters of its previously announced public offering of Class A common stock have exercised their option to purchase an additional 787,500 shares.

February 13, 2012

BOSTON--(BUSINESS WIRE)--OncoPep has licensed a multi-peptide vaccine candidate for hematologic cancers, including multiple myeloma, from the Dana-Farber Cancer Institute. A Phase 1/2a clinical trial is planned for 2012.

February 13, 2012

SAN DIEGO--(BUSINESS WIRE)--The cardiac biomarker ST2 was reported to predict outcomes, mortality and worsening heart failure, in the CORONA heart failure patient study.

February 13, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announced today the start of two clinical initiatives evaluating the broader, real-world clinical use of the company’s Symplicity™ renal denervation system across multiple conditions....

February 13, 2012

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical appoints Thomas J. Sobba as U.S. National Sales Manager for the MicroThermX® Microwave Ablation System line of products.

February 13, 2012

ANDERSON, S.C.--(BUSINESS WIRE)--Poly-Med at MD&M West, highlighting absorbable polymer technologies

February 13, 2012

BOSTON--(BUSINESS WIRE)--OvaScience™, an innovative life science company dedicated to improving the treatment of infertility, today announced that the company will present at the Leerink Swann 2012 Global Healthcare Conference, being held...

February 13, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena starts clinical development of TRV130, a biased ligand mu-opioid agonist for post-operative pain.

February 13, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc., a Leader in Oral Probiotics Care, Presents at BIO CEO & Investor Conference

February 13, 2012

BARCELONA, Spain & AARHUS, Denmark--(BUSINESS WIRE)--Today European scientists are meeting to kick off the 4DCellFate project, funded by the European Commission under the FP7 program. The 4DcellFate project will tackle the question of how the...

February 13, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt’s macular dystrophy (SMD)...

February 13, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has voted to distribute an...

February 13, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced its microarrays were used in a landmark research study on prenatal samples. The three-year study was designed to evaluate the accuracy, efficacy and...

February 13, 2012

TORONTO--(BUSINESS WIRE)--The Asia Pacific orthopedic biomaterials market will grow to nearly $1.3 billion by 2016.

February 13, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO will present a corporate update at the BIO CEO & Investor Conference on Tuesday, February...

February 13, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Pacific Biosciences announced it has released a major upgrade to its PacBio® RS system, referred to as “C2”, including new chemistry, enhanced SMRT Cells and upgraded software.

February 13, 2012

JERUSALEM--(BUSINESS WIRE)--Gamida Cell and Teva Pharmaceutical Industries have enrolled the last of 100 patients in the international, multi-center, pivotal registration, Phase III clinical trial of StemEx.

February 13, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx conference call

February 13, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Jane Wasman, J.D. has been named Chief, Strategic Development. In this new role, Ms. Wasman will oversee the development and execution of the Company’...

February 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS™ (...

February 13, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--The biocatalyst group at Almac has doubled in size in the last year and is reaping rewards with major business growth in chiral building block supply, evolution and commercial manufacture projects as...

February 12, 2012

SINGAPORE--(BUSINESS WIRE)--Quintiles is bolstering its capabilities in Asia -- expanding its Strategic Drug Development and Consulting Practices to Provide a knowledge-based approach.